Adjuvant therapy in malignant melanoma.
Kent
C J
CJ
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114, USA.
Jakobiec
F A
FA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005134:Eye Neoplasms / Q000276:immunology / Q000628:therapy*; D006801:Humans; D006979:Hyperthermia, Induced; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D016685:Mitomycin / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000903:Antibiotics, Antineoplastic; D016685:Mitomycin